Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua Freeman

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Lancet (London, England)|February 24, 2015
Call for transparency in new generation trade dealsJoshua Freeman, Gay Keating, Erik Monasterio, et al.
The New Zealand Medical Journal|February 26, 2016
TPPA should not be adopted without a full, independent health assessmentGay Keating, Joshua Freeman, Alex Macmillan, et al.
Infection Control and Hospital Epidemiology|September 1, 2010
Seroprevalence of measles antibodies among high-risk healthcare workers in Auckland, New Zealand: additional justification for assumption of age-determined immunity based on local dataDeborah Williamson, Joshua Freeman, Paul Austin, et al.
The New Zealand Medical Journal|March 9, 2018
Climate change, human health and the CPTPPOliver Hailes, Rhys Jones, David Menkes, et al.
The New Zealand Medical Journal|November 3, 2016
Combating antimicrobial resistance demands nation-wide action and global governanceScott Metcalfe, Michael G Baker, Joshua Freeman, et al.
The New Zealand Medical Journal|December 16, 2016
Global governance is a key part of the solution to antimicrobial resistance (response to Gravatt)Joshua Freeman, Nick Wilson, Scott Metcalfe, et al.
International Forum of Allergy & Rhinology|November 30, 2012
The characteristics of intramucosal bacteria in chronic rhinosinusitis: a prospective cross-sectional analysisRaymond Kim, Joshua Freeman, Sharon Waldvogel-Thurlow, et al.
American Journal of Infection Control|September 4, 2012
Improved detection of toxigenic Clostridium difficile using the Cepheid Xpert C difficile assay and impact on C difficile infection rates in a tertiary hospital: a double-edged swordDeborah A Williamson, Indira Basu, Joshua Freeman, et al.
The New Zealand Medical Journal|June 26, 2007
Incidence of nontuberculous mycobacterial disease in New Zealand, 2004Joshua Freeman, Arthur Morris, Timothy Blackmore, et al.
The Journal of Antimicrobial Chemotherapy|July 25, 2019
Co-occurrence of mcr-1 and mcr-3 genes in a single Escherichia coli in New ZealandJulie Creighton, Trevor Anderson, Julia Howard, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Lancet (London, England)|February 24, 2015
Call for transparency in new generation trade dealsJoshua Freeman, Gay Keating, Erik Monasterio, et al.
The New Zealand Medical Journal|February 26, 2016
TPPA should not be adopted without a full, independent health assessmentGay Keating, Joshua Freeman, Alex Macmillan, et al.
Infection Control and Hospital Epidemiology|September 1, 2010
Seroprevalence of measles antibodies among high-risk healthcare workers in Auckland, New Zealand: additional justification for assumption of age-determined immunity based on local dataDeborah Williamson, Joshua Freeman, Paul Austin, et al.
The New Zealand Medical Journal|March 9, 2018
Climate change, human health and the CPTPPOliver Hailes, Rhys Jones, David Menkes, et al.
The New Zealand Medical Journal|November 3, 2016
Combating antimicrobial resistance demands nation-wide action and global governanceScott Metcalfe, Michael G Baker, Joshua Freeman, et al.
The New Zealand Medical Journal|December 16, 2016
Global governance is a key part of the solution to antimicrobial resistance (response to Gravatt)Joshua Freeman, Nick Wilson, Scott Metcalfe, et al.
International Forum of Allergy & Rhinology|November 30, 2012
The characteristics of intramucosal bacteria in chronic rhinosinusitis: a prospective cross-sectional analysisRaymond Kim, Joshua Freeman, Sharon Waldvogel-Thurlow, et al.
American Journal of Infection Control|September 4, 2012
Improved detection of toxigenic Clostridium difficile using the Cepheid Xpert C difficile assay and impact on C difficile infection rates in a tertiary hospital: a double-edged swordDeborah A Williamson, Indira Basu, Joshua Freeman, et al.
The New Zealand Medical Journal|June 26, 2007
Incidence of nontuberculous mycobacterial disease in New Zealand, 2004Joshua Freeman, Arthur Morris, Timothy Blackmore, et al.
The Journal of Antimicrobial Chemotherapy|July 25, 2019
Co-occurrence of mcr-1 and mcr-3 genes in a single Escherichia coli in New ZealandJulie Creighton, Trevor Anderson, Julia Howard, et al.
Pageof 7